About Index Trending news
Lists
Pricing
EyeGate Pharmaceuticals, Inc.

EyeGate Pharmaceuticals, Inc.

EyeGate Pharmaceuticals, Inc.

EyeGate Pharmaceuticals develops medicines to treat eye diseases using its non-invasive, iontophoretic drug-delivery system.

Elsewhere

Alexa global traffic share

Latest funding
Post-IPO debt
$3,770,000
Employees

Team size

2
Locations
HQ
Headquarters
Xconomy

EyeGate Deals Treatment Rights to Valeant to Pay for Clinical Trials

Health